Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
2 raisons identifiées
Auteur de référence en rhumatologie
29 articles scientifiques publiés — un praticien à la pointe de la recherche
Délais de RDV courts dans la région
136 rhumatos / 100 000 hab. — département bien doté
✨ Génération du profil synthétique IA en cours…
CABINET DU DR DORA LEVY-ABDULGHANI
166 AVENUE DE VERDUN, 92130 ISSY LES MOULINEAUX
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Journal of translational medicine · 2025
Abstract Introduction Cancer patient’s survival has gradually improved due to immune checkpoint inhibitors (ICIs). Several studies showed a possible association between the intestinal microbiome and ICI efficacy. Strategies for modifying the composition of the gut microbiome encompass various dietary interventions, which may have distinct impacts on the outcomes of ICI-treated patients. In our systematic review, we explored how dietary habits correlate with therapeutic responses in cancer patients and cancer mouse models undergoing immunotherapy. Methods A systematic review was conducted using search terms: “cancer”, “immunotherapy”, “diet”, and “microbiome”, from Medline, Web of Science, Scopus, and Cochrane Library databases. The outcomes in the clinical studies were overall response rate (ORR), overall survival (OS), or progression-free survival (PFS) in human studies. In mouse studies, change in tumor size was the endpoint. The comparator attributions were questionnaire-based dietary interventions. Results Nineteen articles met the inclusion criteria and were included in the review (6 prospective cohort studies, 1 cross-sectional observational study, and 12 mouse studies). A consistent association was observed between high (vs. low) fiber consumption and improved therapeutic response with a pooled odds ratio of 5.79 when including all human prospective cohort studies. In mice, limited availability of methionine, cysteine, and low intake of leucine and glutamine was linked to reduced tumor progression. Combining ICIs with intermittent fasting or a fasting-mimicking diet significantly decreased tumor volume in mouse melanoma models. In humans, a higher relative abundance of short-chain fatty acid (SCFA) and lactic acid-producing bacteria—particularly Faecalibacterium prausnitzii and Akkermansia muciniphila—correlated with objective response rates (ORR). Similar microbiome alterations were observed in mouse models. Increased fiber intake enhanced ICI efficacy in mice by modulating the gut microbiome, primarily via elevated SCFA production—an effect also reflected in human studies. Conclusion Intermittent fasting, high fiber, and low sugar consumption are significantly associated with better ICI outcomes. The studies revealed alterations in microbiota composition linked to diet, and these findings were confirmed in animal models, regarding the production of SCFAs and lactic acid, as well as an increase in Bacteroidota/Bacillota ratio and microbial diversity.
Life sciences · 2025
International journal of biological macromolecules · 2025
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2026 · Journal Article
Corbeau A, Spampinato S, Charnalia M, Ranjan N, et al.
Nanomedicine : nanotechnology, biology, and medicine · 2026 · Journal Article
Narula H, Kamal R, Dhiman S, Singh TG, et al.
BMC medical education · 2026 · Journal Article
da Silva PF, Saurin TA, Fogliatto FS, Dora JM, et al.
The Indian journal of medical research · 2026 · Journal Article
John G, Ghanekar S, Dominic D, Gawde JR, et al.
Frontiers in neuroscience · 2025 · Editorial
Otero-Losada M, Bhave S, Dora D
Journal of cancer research and clinical oncology · 2025 · Journal Article
Thakur P, I V, Dwivedi A, Dora TK, et al.
Urology practice · 2025 · Journal Article
Hampton S, Perry AG, Kumar N, Hochwald AP, et al.
Biomedical physics & engineering express · 2025 · Journal Article
D K, D P, P V, G A, et al.
Life sciences · 2025 · Journal Article
Saka OM, Dora DD, Kibar G, Tevlek A
Frontiers in immunology · 2025 · Journal Article
Dora D, Revisnyei P, Pasic A, Galffy G, et al.
BMC medicine · 2025 · Journal Article
Kumar GA, George S, Majumder M, Dora SSP, et al.
Current pharmaceutical design · 2026 · Journal Article
Garg N, Dhankhar S, Sharma S, Kaur A, et al.
Translational andrology and urology · 2026 · Journal Article
Dalkin B, Dora CD, Baird BA
BMC women's health · 2026 · Journal Article
Behera SM, Behera P, Pal DK, Yadav V, et al.
Journal of translational medicine · 2025 · Journal Article
Somodi C, Dora D, Horváth M, Szegvari G, et al.
Medical sciences (Basel, Switzerland) · 2025 · Journal Article
Sarno M, Pascarella A, De Lucia A, Spennato P, et al.
Endocrine · 2025 · Journal Article
Scheinpflug AL, Walter LB, Marmitt L, Scheffel RS, et al.
Reproductive health · 2025 · Journal Article
Alekhya G, Chinnadurai A, Dora S, Patro SK, et al.
BMC women's health · 2026 · Journal Article
Behera SM, Behera P, Pal DK, Yadav V, et al.
Journal of translational medicine · 2025 · Journal Article
Somodi C, Dora D, Horváth M, Szegvari G, et al.
Endocrine · 2025 · Journal Article
da Rocha BS, Silveira VB, Rados DV, Zanella AB, et al.
Respiratory medicine case reports · 2025 · Case Reports
Cmor N, Dora E, Zitko M, Kocjan T, et al.
Case reports in endocrinology · 2025 · Case Reports
D K, Moradeyo AY, G B
Oxford medical case reports · 2025 · Case Reports
Gupta A, D V, Nawaz A, Hari V
AAPS PharmSciTech · 2025 · Journal Article
Jain S, Mali S, Akhtar J, Dora CP, et al.
Physiology & behavior · 2026 · Journal Article
Yuuki IW, Dora K, Matsumura T, Fukuzawa K, et al.
Endocrine · 2025 · Journal Article
da Rocha BS, Silveira VB, Rados DV, Zanella AB, et al.
BMC women's health · 2026 · Journal Article
Behera SM, Behera P, Pal DK, Yadav V, et al.
Recent advances in inflammation & allergy drug discovery · 2026 · Journal Article
Dhankhar S, Garg N, Mahajan S, Dora CP, et al.
Journal of computer assisted tomography · 2025 · Journal Article
Nakai H, Takahashi H, LeGout JD, Kawashima A, et al.
Journal of translational medicine · 2025 · Journal Article
Somodi C, Dora D, Horváth M, Szegvari G, et al.
Health promotion perspectives · 2025 · Journal Article
Zefack JT, Dora MB, Yankam BM, Fotindong EA, et al.
International journal of biological macromolecules · 2025 · Journal Article
Swami R, Popli P, Sal K, Challa RR, et al.
Archives of microbiology · 2025 · Journal Article
Hashem AH, Saied E, Badr BM, Dora MS, et al.